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Dietary Supplements are Not all Safe and 
Not all Food: How the Low Cost of 
Dietary Supplements Preys on the 
Consumer 
Joanna K. Sax† 
Dietary supplements are regulated as food, even though the safety and efficacy of 
some supplements are unknown. These products are often promoted as ‘natural.’ This 
leads many consumers to fail to question the supplements’ safety, and some consumers 
even equate ‘natural’ with safe. But, ‘natural’ does not mean safe. For example, many 
wild berries and mushrooms are dangerous although they are natural. Another 
example is tobacco—a key ingredient in cigarettes: it is natural, but overwhelming 
studies have established the harm of cigarette smoke. The Food and Drug 
Administration (FDA) requires safety and efficacy testing prior to market entry for 
drugs. In contrast, the FDA only has limited ability to regulate the entry of new dietary 
supplements into the marketplace because supplements are treated as food.  
Two main arguments support the current regulatory structure of dietary 
supplements: (1) cost and (2) access. But lower cost and increased access to dietary 
supplements do not necessary have any relationship to safety and efficacy. 
Manufacturers’ marketing techniques tout the health benefits of their supplements. 
Meanwhile, consumers are ingesting supplements without scientific studies indicating 
whether or not they are harmful. 
The FDA Food Safety and Modernization Act, signed into law on January 4, 2011, 
did not address the safety concerns regarding dietary supplements. This article 
discusses the regulatory deficiencies concerning dietary supplements and proposes 
novel solutions to address this specific sector of the food supply. This article advocates 
for the use of scientific data to support a multi-tiered classification system to ensure 
that dietary supplements on the market are safe.  
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I. INTRODUCTION 
A lot of justifiable concern is spent on the quality and safety of our food supply. 
In 2011, the FDA Food Safety and Modernization Act (FSMA) was signed into law.1 
The FSMA provides the Food and Drug Administration (FDA) with a legislative 
mandate to enforce preventative measures to shore-up our food system and improve 
safety.2 Under the FSMA, the FDA has the authority to act in the following key areas: 
to prevent contamination of foods, to respond to potential food safety issues, to 
improve food importation standards, and to create partnerships to ensure the safety of 
our food supply.3  
While the FSMA is designed to address, detect, prevent and respond to food 
safety issues, it is noticeably lacking any real regulations addressing the health and 
safety issues surrounding dietary supplements. Under the Dietary Supplement Health 
and Education Act (DSHEA), dietary supplements are regulated as food.4 The thirty 
billion dollar per year supplement industry has its fair share of safety issues.5 
Regardless, the FDA is limited in its ability to regulate the dietary supplement 
industry. While many supplements on the market are safe, the safety of other 
supplements is unknown.  
The FSMA provides authority to the FDA and notice to food manufacturers that if 
the Secretary reasonably believes that exposure to an article of food “will cause serious 
adverse health consequences or death to humans or animals, each person (excluding 
farms and restaurants) who manufactures, processes, packs, distributes, receives, 
holds, or imports such article shall . . . have access to and copy all records relating to 
such article.”6 The FSMA, however, explicitly excludes the application of this law to 
dietary supplements by stating that “[n]othing in the amendments made by this section 
shall apply to any facility with regard to the manufacturing, processing, packing, or 
holding of a dietary supplement.”7 The only section in the FSMA that creates any 
administrative rights for the FDA is section 113.8 Section 113 gives the Secretary 
rights to notify the Drug Enforcement Administration if any ingredient in a dietary 
supplement may be or may contain an anabolic steroid.9 
While the manufacturing, importation, transportation, and handling of our 
traditional food supply poses challenges that are distinct from dietary supplements, this 
article will highlight the safety concerns with dietary supplements and discuss how the 
current regulatory framework is ill-equipped to handle the serious health consequences 
associated with this industry. The FSMA, enacted to provide consumers with a safe 
food supply, does little to address safety and efficacy problems that exist in the use of 
dietary supplements.  
Part II of this Article will provide background information describing the dietary 
supplement industry, including what constitutes a dietary supplement. Part III will 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 U.S. FOOD & DRUG ADMIN., FSMA FACTS: FOOD SAFETY LEGISLATION KEY FACTS 1 (2011), 
available at http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM263777.pdf. 
2 See U.S. FOOD & DRUG ADMIN., FSMA FACTS: BACKGROUND ON THE FDA FOOD SAFETY 
MODERNIZATION ACT (FSMA) 1 (2011), available at http://www.fda.gov/downloads/Food/ 
GuidanceRegulation/UCM263773.pdf. 
3 Id. at 1-2. 
4 21 U.S.C. § 321(ff) (2012). 
5 Natasha Singer & Peter Lattman, A Workout Booster, and a Lawsuit: A Death Points Up a Gap In 
Rules on Supplements, N.Y. TIMES, Feb. 14, 2013, at B1, available at http://www.nytimes.com/2013/ 
02/14/business/death-after-use-of-jack3d-shows-gap-in-regulation.html?pagewanted=all. 
6 FDA Food Safety Modernization Act § 101(a)(4), 21 U.S.C. § 350c(a)(2). 
7 FDA Food Safety Modernization Act § 103(g), 21 U.S.C. § 350g. 
8 FDA Food Safety Modernization Act § 113, 21 U.S.C. § 350b. 
9 21 U.S.C. § 350b(c)(1). 
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highlight safety and efficacy concerns for consumers who use dietary supplements. 
This section includes a description of some scientific studies analyzing the safety, 
interactions, and composition of various dietary supplements. The purpose of this 
section is to demonstrate that we have limited scientific information about 
supplements, especially when considering the breadth and depth of the types of 
supplements on the market. The next section, Part IV, will describe the regulatory 
deficiencies regarding dietary supplements and propose novel solutions to address this 
specific section of the food supply. Other legal scholars have focused on the lawsuits 
or other legal authority.10 This article takes a different approach by combining law and 
science to demonstrate that the DSHEA is inadequate to regulate the current dietary 
supplement industry. The DSHEA is outdated and even its findings—that is, the 
purpose for the DSHEA—can no longer be supported. It is likely that the growth of the 
industry outgrew the purpose of the Act. This Article will thus challenge the efficacy 
of the DSHEA in light of what we learned over the past 20 years. Importantly, this 
Article calls for policy decisions to be made by or supported by scientific studies 
establishing safety. Efficacy would be a welcome addition, although the pressing and 
primary concerns are about safety. Finally, this Article concludes that the FSMA failed 
to address the concerns about the dietary supplement industry. The discussion is 
warranted given the multitude of issues that the FDA must address when ensuring a 
safe food supply. 
II. GENERAL INFORMATION ABOUT THE DIETARY SUPPLEMENT 
INDUSTRY 
The dietary supplement industry is a thirty billion dollar per year endeavor.11 
Dietary supplements include vitamins, essential minerals, protein, amino acids, and 
herbs.12 Dietary supplements are classified as food.13 This classification is important 
for regulatory purposes because it defines the categorization and authority by the FDA 
to regulate this industry. Since 1994, this portion of the food supply has been regulated 
under the DSHEA.14 The DSHEA provides that the FDA can respond to proof of 
harmful ingredients in dietary supplements, but it does not provide any authority 
similar to the FDA’s ability to regulate drugs prior to the entry to market.15 
Manufacturers therefore maintain a lot of control when bringing supplements to 
market because they do not have to obtain FDA approval.16 This is problematic in part 
because, as will be discussed below, some dietary supplements contain pharmaceutical 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 Michael A. McCann, Dietary Supplement Labeling: Cognitive Biases, Market Manipulation & 
Consumer Choice, 31 AM. J.L. & MED. 215, 219 (2005). 
11 David Lariviere, Nutritional Supplements Flexing Muscles As Growth Industry, FORBES (Apr. 18, 
2013, 7:09 PM), http://www.forbes.com/sites/davidlariviere/2013/04/18/nutritional-supplements-flexing-
their-muscles-as-growth-industry/. 
12 U.S. FOOD & DRUG ADMIN., DIETARY SUPPLEMENTS: WHAT YOU NEED TO KNOW 1 (2006), 
available at http://www.fda.gov/downloads/Food/DietarySupplements/UCM240978.pdf. 
13 21 U.S.C. § 321(ff) (2012); Questions and Answers on Dietary Supplements, U.S. FOOD & DRUG 
ADMIN., http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/default.htm (last updated 
Apr. 28, 2015). 
14 See Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat. 4325 
(codified as amended in scattered sections of 21 U.S.C.). 
15 21 U.S.C. §§ 350c(a)(1), 355 (2012); Rahi Azizi, Comment, “Supplementing” the DSHEA: 
Congress Must Invest the FDA with Greater Regulatory Authority over Nutraceutical Manufacturers by 
Amending the Dietary Supplement Health and Education Act, 98 CALIF. L. REV. 439, 444 (2010). 
16 Azizi, supra note 15, at 440, 443. 
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or pharmaceutical-like ingredients; this challenges the notion that all supplements 
should be classified as food.17  
Consumers are not necessarily aware that dietary supplements, often sold down 
the aisle from FDA approved over-the-counter (OTC) drugs (also known as non-
prescription drugs), are not tested for safety or efficacy prior to market entry. In fact, 
some consumers prefer dietary supplements to OTC drugs because they prefer not to 
take drugs for some ailments.18 Manufacturers exploit this preference in their 
marketing techniques, by touting their supplement as ‘natural.’19 The perception of 
some consumers is that anything that is natural is safe.20 But, of course, that is not true. 
Many poisonous and dangerous things are natural, such as wild mushrooms.21 Tobacco 
is another natural ingredient that is linked to adverse health consequences.22  
On top of the ‘natural = safe’ problem, information is lacking about how dietary 
supplements interact with each other or with other drugs. For example, evidence 
suggests that a popular dietary supplement, St. John’s Wort (SJW), causes adverse 
consequences when it interacts with certain drugs.23 While we have some information 
about supplements’ adverse interactions, the data is limited. Few scientific studies 
address possible interactions. In part, this is because there are so many supplements on 
the market. It also may be because it is challenging to hypothesize about interactions 
that unknown ingredients at unknown concentrations may cause. Part III, below, will 
provide information about the problems with content and formulation. 
Consumers are often unaware that dietary supplements for medical and medical-
like conditions are not FDA approved.24 In an industry-sponsored study, 3,500 
Americans were surveyed about their use of dietary supplements for weight loss.25 The 
results of the study revealed that many respondents believed that not only were weight-
loss supplements approved for safety and efficacy prior to market, but that weight-loss 
supplements were actually safer than OTC or prescription medications.26 This study 
was sponsored by the pharmaceutical company GlaxoSmithKline, who had just 
received FDA approval for a non-prescription weight loss drug.27 Presumably, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
17 See infra Part II. 
18 McCann, supra note 10, at 219. 
19 See id. at 222, 226-27. 
20 Id. at 226; see also U.S. FOOD & DRUG ADMIN., MIXING MEDICATIONS AND DIETARY 
SUPPLEMENTS CAN ENDANGER YOUR HEALTH 2 (2014), available at http://www.fda.gov/ 
downloads/ForConsumers/ConsumerUpdates/UCM420449.pdf. 
21 See, e.g., Cat Adams, The Most Dangerous Mushroom, SLATE (Feb. 10, 2014, 10:05 AM), 
http://www.slate.com/articles/health_and_science/medical_examiner/2014/02/most_dangerous_mushroom_
death_cap_is_spreading_but_poisoning_can_be_treated.single.html. 
22 See Cigarette Smoking, AM. CANCER SOC’Y (Feb. 20, 2014), http://www.cancer.org/acs/groups/ 
cid/documents/webcontent/002967-pdf.pdf. 
23 See Marcus Mannel, Drug Interactions with St John’s Wort: Mechanisms and Clinical Implications, 
27 DRUG SAFETY 773, 788 (2004) (“Although evidence is rather weak, the risk of developing serotonin 
syndrome and other central adverse reactions cannot be ruled out. Therefore, combinations of St John’s wort 
with psychotropic medications, in particular with serotonergic drugs (e.g. SSRIs, tricyclic antidepressants, 
venlafaxine, tryptophan, tramadol, buspirone) and other antidepressants, should be used cautiously.”); 
Advisory Letter from Murray M. Lumpkin, Deputy Ctr. Dir., Food & Drug Admin. Ctr. for Drug Evaluation 
& Research, and Susan Alpert, Dir. of Food Safety, Food & Drug Admin. Ctr. for Food Safety & Applied 
Nutrition, to Health Care Professionals (Feb. 10, 2000) [hereinafter Letter from Lumpkin] (on file with Food 
& Drug Admin.), available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformation 
forPatientsandProviders/ucm052238.htm. 
24 See Janine L. Pillitteri et al., Use of Dietary Supplements for Weight Loss in the United States: 
Results of a National Survey, 16 Obesity 790, 794 (2008). 
25 Id. at 790. 
26 Id. at 790, 793-94. 
27 Id. at 795.  
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GlaxoSmithKline was interested in market analysis of consumer preference for non-
prescription drugs versus dietary supplements for weight loss. The results demonstrate 
a disconnect between consumers and their understanding of the regulatory oversight of 
drugs and supplements. Consumers appear to actually trust dietary supplements more 
than FDA approved drugs—and this might, in part, be due to good marketing 
techniques. Weight loss supplements are actually among the most potentially 
dangerous supplements; studies show that they are more likely to contain active or 
adulterated pharmaceuticals—even some that are banned.28 This makes it difficult for a 
consumer to decipher which weight loss supplements are safe and which are unsafe. 
Many consumers take vitamin supplements. Companies market to different age 
groups, telling consumers to buy children’s vitamins to assist with brain development 
or to buy vitamins that are made specifically for seniors.29 It turns out that it is not 
clear that use of all vitamins is safe or effective. There is no scientific consensus that 
vitamin supplements actually improve health.30 While it is true that specific vitamins 
can prevent certain ailments—for example, Vitamin C can prevent scurvy— it is 
unclear whether vitamins offer any health benefits to healthy people.31 On top of that, 
too much of a particular vitamin can actually lead to health problems.32 Other 
problems with vitamins include that different brands may contain different amounts of 
active ingredients, and the level of absorption may be different when vitamins are 
taken as a supplement rather than ingested through food.33 
Consumers like the lower cost of dietary supplements as compared to drugs, and 
the autonomy associated with dietary supplements.34 If FDA approval were required, 
then the cost of supplements would increase because the cost of clinical trials would be 
passed along to the consumer. Studies demonstrate that consumers in lower income 
brackets tend to be higher users of supplements.35 This begs the question of why 
consumers in lower income brackets are more likely users—is higher use caused by 
the industry’s marketing techniques, or by the consumer’s lack of education or lack of 
access to high quality foods? It may be a combination of these factors as well as 
others. 
Regulation of dietary supplements faces the same conflict between paternalism 
and autonomy that arises in any other area of regulation. 36 Consumers appreciate the 
freedom and choice associated with choosing to purchase dietary supplements. Many 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
28 Pieter A. Cohen, American Roulette — Contaminated Dietary Supplements, 361 NEW ENG. J. MED. 
1523, 1524 (2009). 
29 See, e.g., Corey H. Basch et al., An Examination of Marketing Techniques Used to Promote 
Children’s Vitamins in Parenting Magazines, 7 GLOBAL J. HEALTH SCI. 171, 174 (2015); Chris Daniels, 
Grey Power and Vitamin Sales: Whitehall-Robins is Using a Seniors-Targeted TV Show to Pep Up its 
Centrum Brand, MARKETING MAG., Aug. 24/31 1998, at 24. 
30 Melinda Wenner Moyer, Vitamins on Trial: After Decades of Study, Researchers Still Can’t Agree 
on Whether Nutritional Supplements Actually Improve Health, 510 NATURE 462, 462 (2014). 
31 Id.  
32 Katherine Zeratsky, What is vitamin D toxicity, and should I worry about it since I take 
supplements?, MAYO CLINIC (Feb. 5, 2015), http://www.mayoclinic.org/healthy-living/nutrition-and-
healthy-eating/expert-answers/vitamin-d-toxicity/faq-20058108; see also Tara Parker-Pope, The Case 
Against Vitamins, WALL ST. J., Mar. 20, 2006, at R1, R3; Pillitteri et al., supra note 24, at 795. 
33 Coco Ballantyne, Fact or Fiction?: Vitamin Supplements Improve Your Health, SCI. AM. (May 17, 
2007), http://www.scientificamerican.com/article/fact-or-fiction-vitamin-supplements-improve-health/ (“The 
best way to get vitamins is through food, not vitamin pills, according to Susan Taylor Mayne, a professor at 
the Yale School of Public Health's Division of Chronic Disease Epidemiology.”). 
34 McCann, supra note 10, at 259. 
35 Id. at 224.  
36 Joanna K. Sax, The Tobacco Diaries: Lessons Learned and Applied to Regulation of Dietary 
Supplements, 73 MD. L. REV. ENDNOTES 20, 23 (2013). 
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believe that the government does not and should not decide what can and cannot be on 
the market, and that consumers should have some say in the process. This argument 
continues that if dietary supplements really are harmful, then the market will speak and 
there will be no demand for them. With enough injuries or lawsuits, the market will 
correct itself. Of course, this argument is based on rational choices and there is an 
entire body of literature challenging the assumption of rational decision-making.37 The 
counterargument is that, in the absence of regulation, consumers may be harmed by 
ingestion of harmful supplements. Just as the FDA is charged with securing a safe food 
supply, the FDA should have the same ability to ensure a safe dietary supplement 
supply. The contours of these arguments are similar to arguments made by smokers 
who want the autonomy to purchase cigarettes, even in the face of all of the data 
demonstrating the health risks they pose.  
In this tension between autonomy and government regulation, it is unclear why 
consumers are or should be trusting of manufacturers, especially to the extent that they 
trust manufacturers more than they trust the government. Recent reports suggest that 
some manufacturers of dietary supplements alter the chemical structure of known 
drugs in order to avoid being classified as a drug and prompting the FDA regulatory 
approval process.38 For example, multiple deaths have been associated with a work-out 
booster called “Jack3d,”39 which contains dimethylamine, described by the medical 
literature as a “synthetic stimulant similar to amphetamines.”40 While the government 
is an imperfect actor, the FDA has some credibility with respect to testing the safety 
and efficacy of drugs. As of now, however, the FDA has little authority to regulate 
supplements as they go on the market.41  
Consumers are making blind choices when choosing many of the supplements on 
the market. Manufacturers may classify a particular supplement in a weight-loss 
assistance category, but the manufacturer may not have any real data to support this 
classification. In fact, some weight-loss supplements combine active ingredients that 
mask the detrimental effects of other ingredients.42 For example, contaminants in 
weight-loss supplements such as benzodiazepines and anti-depressants mask the side 
effects of stimulants within the same pill.43 Scientific data and consensus are lacking 
on the true benefits of many supplements on the market.44 That could be in part 
because the FDA does not and cannot require clinical trials prior to entry to market.  
Scientific data exists for only a small portion of the supplements on the market. 
What data shows about some of the supplements may surprise consumers. Some 
supplements that consumers might be pre-disposed to think of as safe have actually 
been demonstrated to increase mortality or adversely interact with a number of drugs.45 
To fully comprehend the breadth of problems associated with the lack of regulation of 
dietary supplements, policymakers, lawyers, and consumers need an overview of the 
scientific studies that examine supplements’ content, formulation, active ingredients, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
37 See Joanna K. Sax, Financial Conflicts of Interest in Science, 21 ANNALS HEALTH L. 291, 310-15 
(2012) (citing examples). 
38 Cohen, supra note 28, at 1524. 
39 Singer & Lattman, supra note 5, at B1. 
40 Id. at B2. 
41 See Cohen, supra note 28, at 1523-24. 
42 Id. at 1524-25. 
43 Id. 
44 See Jaakko Mursu et al., Dietary Supplements and Mortality Rate in Older Women: The Iowa 
Women’s Health Study, 171 ARCHIVES INTERNAL MED. 1625, 1625 (2011). 
45 Id. at 1631; Letter from Lumpkin, supra note 23. 
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and interactions. When addressing the autonomy versus paternalism arguments, the 
interested parties must rely on science to shape their arguments.  
III. WHAT DO WE KNOW ABOUT VARIOUS DIETARY SUPPLEMENTS? 
Because dietary supplements are regulated as food, there is little or no safety 
testing requirement prior to entry on the market.46 The standards of active or actual 
ingredients within and among supplements may vary. For example, different 
manufacturers of Vitamin D may have different manufacturing processes that lead to 
different amounts of Vitamin D in each pill, even within the same bottle.47 Much of 
this depends on the practices of the manufacturer.48 While manufacturers of dietary 
supplements are supposed to follow the “Good Manufacturing Processes” as 
established by the FDA, the FDA does not ensure the quality.49 This is unlike drugs, 
where the amount of active ingredient is regulated.50 Some independent organizations 
offer “seals of approval,” but these organizations set their own standards, and 
manufacturer participation is voluntary.51 In any case, these organizations do not test 
for safety or efficacy.52 Furthermore, the Office of Dietary Supplements (ODS), which 
is part of the National Institutes of Health (NIH), does not maintain lists of dietary 
usage or sale.53 
Since many consumers do not fully understand the different regulatory structures 
governing supplements and over-the-counter drugs, consumers may not understand 
that the consistency and purity of supplements may not match what is required for 
OTC drugs.54 This confusion may contribute to consumer trust that the labels on 
dietary supplements actually match the content. In reality, however, the quality control 
standards for dietary supplements vary by manufacturer.55 The literature has 
documented many causes for concern, including contamination, species 
misidentification, adulteration of pharmaceuticals, and content that deviates from label 
claims.56 
Many active pharmaceuticals are derived from plants. One general category of this 
is ephedra alkaloids, which are derived from the plant genus Ephedra.57 Numerous 
FDA-approved OTC drugs contain forms of ephedra alkaloids as bronchodilators, 
decongestants and appetite suppressants.58 One form of ephedra alkaloid, (+)-
norpseudoephedrine is classified as a Schedule IV controlled substance.59 Ephedra 
alkaloids in supplements are often marketed as workout boosters or weight loss tools.60 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
46 McCann, supra note 10, at 220; Azizi, supra note 15, at 440. 
47 See Erin S. LeBlanc et al., Over-the-Counter and Compounded Vitamin D: Is Potency What we 
Expect?, 173 JAMA INTERN MED. 585, 585-86 (2013). 
48 See Frequently Asked Questions (FAQ), NAT’L INST. HEALTH http://ods.od.nih.gov/ 
Health_Information/ODS_Frequently_Asked_Questions.aspx#Ingredients (last reviewed July 1, 2013) 
[hereinafter FAQ]. 
49 Id.  
50 See 21 U.S.C. § 355 (2012). 
51 FAQ, supra note 48.  
52 Id. 
53 Id. 
54 Cf. Bill J. Gurley et al., Content Versus Label Claims in Ephedra-Containing Dietary Supplements, 
57 AM. J. HEALTH-SYS. PHARMACY 963, 963 (2000). 
55 Cf. id.  
56 Id. 968-69 (collecting examples).  
57 Id. at 964. 
58 Id.  
59 Id.  
60 Id. 
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The label of a dietary supplement may state that the supplement contains ephedra 
alkaloids, but may not state which forms of the alkaloids and in what quantity.  
Researchers at the University of Arkansas for Medical Sciences conducted a study 
analyzing the content and consistency of ephedra alkaloids in twenty ephedra-
containing dietary supplement products using high-performance liquid 
chromatography.61 This group found a variety of different ephedra alkaloids in many 
of the products, with some products varying lot-to-lot.62 The researchers also found 
that the label claims of ephedra content did not match the measured amounts of (-)-
ephedrine or total alkaloids.63 For some products, the label claimed a much smaller 
amount of ephedra than what was actually in the product, while in others, the label 
claimed more ephedra than was in the product.64 The researchers found that “ [i]n total, 
11 (55%) of the 20 supplements either failed to make a label claim for alkaloid content 
or exceeded a 20% difference between alkaloid content and label claim.”65 
Importantly, many adverse health events and even deaths have been attributed to 
ephedra.66 Recall, ephedra is taken from the plant genus Ephedra; consumers may be 
lured in by advertising claiming that the supplement is ‘natural.’ 
Not only is there a problem with labels matching content, but the combination of 
specific types of ephedra alkaloids with caffeine, which is also used as a workout 
enhancer, merely mimics a naturally combined alternative to amphetamine drugs, 
which FDA has banned.67 Moreover, even if a label states the precise alkaloids 
content, the content of different types of ephedra within the supplement remains 
unclear.68 And, the manner by which the ephedra alkaloids are obtained, such as 
through extracts or powdered herb will affect the absorption rate by the gastrointestinal 
tract.69 It seems unrealistic that consumers understand different forms of ephedra 
alkaloids, how the ephedra is obtained and the difference in absorption rates. Even if 
comprehension weren’t a concern, access to this information is difficult to obtain.  
Serious safety concerns about workout supplements have arisen. In 2013, The 
New York Times reported a story about a wrongful death lawsuit filed by the parents of 
a soldier who died after taking a workout booster called “Jack3d.”70 Jack3d contained 
a stimulant, dimethylamyline (DMAA), which can raise a person’s heart rate and 
blood pressure.71 DMAA was originally developed by the pharmaceutical giant Eli 
Lilly in the 1940s to be used as a nasal inhaler to assist with congestion.72 The medical 
literature describes DMAA as a synthetic stimulant, similar to amphetamines, which 
can increase the risk of a heart attack.73 After becoming aware of the risk it posed, the 
FDA issued warning letters to USPlabs, the manufacturer of Jack3d.74 In light of the 
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74 Warning Letter from Michael W. Roosevelt, Acting Dir., Office of Compliance, Food & Drug 
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health and safety concerns associated with Jack3d, some trade groups and consumers 
complain that the FDA did not and is not doing enough to protect the public health.75 
The FDA’s hands are tied, however. Without additional regulatory authority, the FDA 
is limited in its ability to investigate or to take further action. 
Variations between actual content and claimed content also exist in vitamin 
supplements.76 Multiple studies found both overages and underages for a number of 
vitamins, including Vitamins A, B12, K, D, E, and folic acid.77 Besides the obvious 
problem that the label does not accurately depict content, it is also difficult to evaluate 
whether any supplement is improving health if it is unknown how much of a vitamin 
the consumer is actually taking.  
Independent of the fact that many labels do not accurately reflect supplement 
content, it remains unresolved what measure should be used to calculate the content—
should it be absorption rate, biological effect, something else?78 That is, a problem 
exists to even calculate content—content is not simply the amount of active ingredient; 
for some ingredients, a consumer may be more interested in the absorption rate. If a 
label only measures one aspect of a supplement, it may not be communicating to the 
consumer the actual impact of the biologic. 
Manufacturers can voluntarily associate with the National Products Association 
(NPA) and be approved as a manufacturer with good manufacturing practices (GMP), 
but the NPA is a non-profit association with no regulatory authority.79 While 
manufacturers are required to be in compliance with the FDA’s GMP, the FDA does 
not investigate the manufacturer’s processes until there is a problem.80 That is, the 
current regulatory framework does not give the FDA the ability to regulate the 
manufacturing processes and content claims prior to entry to market. This means that 
the consumer needs to be independently educated about content and interactions, 
which is an unrealistic expectation.  
The best way to find out about the safety and efficacy of dietary supplements is to 
read and understand the peer-reviewed scientific literature, where available. Since 
most consumers do not regularly subscribe to and read peer-reviewed scientific 
literature, this medium is a limited and ineffective way to provide information to 
consumers. Described below are a few scientific studies about a small number of 
dietary supplements. 
One concern is that there is no scientific consensus about the efficacy of vitamins 
in healthy populations.81 If you have a healthy diet and no deficiencies, then you can 
probably stop buying any vitamins. Actually, too much of particular supplements are 
associated with harm. For example, a recent report demonstrated that the use of 
supplemental iron in older women was correlated with increased mortality.82 It is 
unclear from this study whether the women taking supplemental iron had iron 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
75 See, e.g., Singer & Lattman, supra note 5, at B2. 
76 See Elizabeth A. Yetley, Multivitamin and Multimineral Dietary Supplements: Definitions, 
Characterization, Bioavailability, and Drug Interactions, 85 AM. J. CLINICAL NUTRITION (SUPPLEMENT) 
269s (2007). 
77 Id. at 270s-71s. 
78 Cf. id. at 272s.  
79 NPA GMP Certification Program, NAT. PRODUCTS ASS’N, http://www.npainfo.org/NPA/ 
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80 Monika Samtani et al., Remarks During a Satellite Broadcast on Current Good Manufacturing 
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deficiencies or not, but the mortality rate is certainly something to consider. If an older 
woman has no iron deficiency, then she is at risk for dying sooner if she takes 
supplemental iron. If an older woman has an iron deficiency, she should have a 
discussion with her physician about the risks of supplemental iron and any potential to 
change her diet. Importantly, the decision to take a supplement should be an informed 
medical decision. 
We also know little about the interaction of many supplements with drugs. One 
supplement that has been studied with respect to interactions with drugs is SJW. 
Consumers use SJW externally to treat wounds or burns or internally to treat fevers or 
depression.83 Scientific studies establish a number of significant clinical interactions 
with prescription drugs, including HIV protease inhibitors and oral contraceptives, 
resulting in decreased effect of these medications.84 Consumers might know this if 
they searched the scientific peer-reviewed literature and read the following abstract: 
A number of clinically significant interactions have been identified with 
prescribed medicines including warfarin, phenprocoumon, cyclosporin, 
HIV protease inhibitors, theophylline, digoxin and oral contraceptives 
resulting in a decrease in concentration or effect of the medicines. These 
interactions are probably due to the induction of cytochrome P450 
isoenzymes CYP3A4, CYP2C9, CYP1A2 and the transport protein P-
glycoprotein by constitutent(s) in SJW. The degree of induction is 
unpredictable due to factors such as the variable quality and quantity of 
constituent(s) in SJW preparations.85 
After reading this abstract, consumers would know that adverse drug interactions 
occur depending on the quality and quantity of the preparation.86 Then, a consumer 
could try to determine the correct concentration as stated on the label of the SJW, 
which, as discussed above may not actually be accurate.  
Of course, reviewing scientific research and understanding compounding is 
completely unrealistic for the vast majority of consumers. This means that consumers 
likely do not have the information to make an informed decision about the safety of 
supplements. 
The ODS has a nice webpage that describes drug interactions with a variety of 
dietary supplements.87 The website has a link to information on Calcium, a common 
dietary supplement, which can interact with a variety of drugs by reducing the 
absorption rate.88 Examples of effected drugs include: Bisphosphonates (to treat 
osteoporosis), Antibiotics of the fluoroquinolone and tetracycline families, 
Levothyroxine (to treat low thyroid activity), Phenytoin (an anticonvulsant), and 
Tiludronate disodium (to treat Paget's disease).89 Some consumers may be aware that 
one should not take certain medications with milk and may think to worry about 
absorption rates; it is unlikely, however, that the typical consumer is aware of these 
drug interactions.  
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Acai, a popular berry that appears in many smoothies, fruit bars and is 
incorporated in other food, has recently been an ‘it’ food that is supposed to have 
beneficial characteristics.90 Now it is sold as a supplement.91 No scientific studies 
establish that acai will help people age gracefully.92 It may be that acai has some anti-
oxidant qualities, as do other types of fruit.93 Nothing is known about its potential 
benefits as a supplement or whether it interacts with other drugs or supplements.94 
Consumers may be opening their wallets to purchase a supplement with no known 
benefits. 
While the ODS website is nicely organized, it is limited to a small percentage of 
the types of dietary supplements on the market; many of the drug interactions, allergic 
reactions, and any meaningful study of any possible health benefits is lacking for most 
of the supplements on the market. Even if most consumers stayed up to date on the 
medical and scientific literature regarding supplements, which they do not, there is not 
enough information about safety, efficacy, and drug interactions to make informed 
choices. Additional scientific studies are needed to analyze dietary supplements, but 
the number of supplements on the market makes this a daunting task. 
One might think that consumers could simply call their physicians and ask about 
possible adverse events. It turns out, however, that 
[a] recent survey of more than 300 residents in internal medicine from 
15 U.S. training programs showed that one third of the respondents 
believed that dietary supplements require FDA approval, and the 
majority did not know that adverse events suspected to have been caused 
by supplements should be reported to the FDA.95 
This startling information illustrates the problem that the majority of consumers 
believe that dietary supplements have been approved by a government agency.96 
Drug interactions are not the only serious concern with dietary supplements; some 
dietary supplements contain undeclared active pharmaceutical ingredients.97 A 2009 
report stated that more than 140 products contaminated with pharmaceutical 
ingredients have been identified, but that this most likely represents only a small 
fraction of the actual contamination.98 Some of the contaminating ingredients include 
drugs that the FDA has rejected to approve because they were not shown to be safe.99 
The story becomes worse when manufacturers incorporate pharmaceutical 
analogues into the supplement.100 The addition of a hydroxyl group, for example, 
modifies a known pharmaceutical in such a way that it becomes difficult, if not 
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impossible, to detect the pharmaceutical.101 The risks of this modified pharmaceutical 
remains unknown.102 
Even with the parade of horribles described above, there are times in which it is 
appropriate to take dietary supplements. As soon as a woman becomes pregnant, she 
may be instructed to stop taking many medications and supplements, but she is often 
advised to take folic acid, a dietary supplement. 103 Folic acid, a vitamin B, has been 
shown to be important in neural tube development in the developing fetus.104 “Women 
who take folic acid vitamin supplements before and during early pregnancy are less 
likely to have babies with neural tube defects than women who do not take folic 
acid.”105 Scientific consensus supports the nexus between folic acid and neural tube 
formation, but it is unclear whether a diet rich in folic acid would make use of the 
supplement unnecessary. While folic acid is a recommended supplement during 
pregnancy, consumers still need to be concerned about the formulation of the 
supplement in the marketplace—regulation of formulation would most likely better 
support safe and effective use of folic acid. 
Some scientific studies may support the use of supplements, as is the case with 
folic acid. This is not surprising considering that many scientific studies support the 
use of non-prescription and prescription drugs. Requiring manufacturers to work 
through a regulatory process is advantageous in that at least some scientific analysis is 
conducted to support the claimed use and there is regulatory authority to oversee 
content, formulation, and purity.  
The current landscape requires that a comprehensive regime be created to regulate 
dietary supplements so that safe and effective supplements are available to consumers. 
Not all supplements are unsafe or ineffective; indeed, some are both safe and effective. 
The problem is that there is little consistency regarding the products in the 
marketplace. Or, at least, it is difficult for consumers to know which supplements are 
safe and effective. This is the result of the deregulation of dietary supplements under 
the DSHEA.106 It has now been twenty years since the DSHEA was enacted and 
implemented. It is time to reflect and consider whether and how the FDA should 
regulate the breadth and depth of the dietary supplement industry. 
IV. REGULATORY MILIEU AND SHORTCOMINGS 
When the DSHEA was passed in 1994, it changed the regulatory regime for 
dietary supplements. Prior to the DSHEA, herbal products were regulated as food 
additives, which meant that manufacturers were required to demonstrate they were 
safe prior to market entry.107 After the DSHEA, a presumption of safety was given to 
dietary supplements, creating little barrier to entry.108 The FDA only has the authority 
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to remove dietary supplements upon a clear showing that the supplement is unsafe.109 
Since many adverse events go unreported, this leaves little regulatory oversight for 
dietary supplements. 
A. DSHEA FINDINGS 
Without delving into whether the DSHEA was a good idea at the time it was 
passed, we can certainly analyze whether it has met its objectives now that it has been 
twenty years since its enactment. This Article will focus on some of the findings in the 
DSHEA to determine whether this regulatory regime is appropriate or requires 
amendment. 
The following are a few of the findings as stated in section 2 of the DSHEA: 
. . . (2) the importance of nutrition and the benefits of dietary 
supplements to health promotion and disease prevention have been 
documented increasingly in scientific studies; . . . 
. . . (4) healthful diets may mitigate the need for expensive medical 
procedures, such as coronary bypass surgery or angioplasty; . . .  
. . . (8) consumers should be empowered to make choices about 
preventive health care programs based on data from scientific studies of 
health benefits related to particular dietary supplements; . . . 
. . . (12)(A) the nutritional supplement industry is an integral part of 
the economy of the United States; . . . 
. . . (14) dietary supplements are safe within a broad range of intake, 
and safety problems with the supplements are relatively rare.110 
It is important to analyze whether these findings have proven to accurately 
represent the dietary supplement industry.  
Finding (2) in the DSHEA provides that dietary supplements are important for 
disease prevention and health promotion based on scientific studies.111 While it is 
correct that a dietary supplement may promote health in an individual that has a 
deficiency, there is no scientific consensus that supplemental vitamins have any health 
benefits in individuals with healthy diets.112 Actually, there is scientific evidence that 
the ingestion of certain supplements by healthy individuals may be associated with 
deleterious health consequences.113 In addition, it is certainly arguable as to whether 
other types of supplements, such as workout boosters promote health and prevent 
disease. At the very least, scientific studies are need to determine this.  
Finding (4), which addresses that healthy individuals are less likely to have 
medical problems, has a tenuous if any relationship to dietary supplements.114 It is 
correct that an individual with a healthy diet is less likely to experience certain medical 
problems compared to an individual with an unhealthy diet. An illustration of this is 
the link between obesity and diabetes.115 This finding is so general that it is easy to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
109 See 21 U.S.C. § 342(a)(1) (2012). 
110 Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, § 2, 108 Stat. 4325, 
4325-26 (codified as amended in scattered sections of 21 U.S.C.). 
111 Dietary Supplement Health and Education Act § 2(2). 
112 Moyer, supra note 30, at 462. 
113 See Mursu et al., supra note 44, at 1625. 
114 Dietary Supplement Health and Education Act § 2(4). 
115 Diabetes Guide, WEB MD, http://www.webmd.boots.com/diabetes/guide/risk-factors-for-diabetes 
(last visited May 13, 2015) (“Diabetes has long been linked to obesity and being overweight. Research at the 
DIETARY SUPPLEMENTS ARE NOT ALL SAFE 387 
challenge by discussing genetic diseases and genetic predispositions to diseases. This 
finding might be trying to state that dietary supplements will contribute to a healthful 
diet; if it does stand for this proposition, it suffers from the same defects as finding (2) 
does.  
Finding (8) addresses the autonomy of consumers, which is the dominant 
argument against any meaningful regulation of the dietary supplement industry.116 
Interestingly, this finding provides that consumers should be allowed to make their 
own choices “based on data from scientific studies,”117 which is problematic for two 
reasons. First, there is a lack of scientific studies on many of the dietary supplements 
on the market. Second, it is unlikely that the typical consumer is able to dedicate the 
time to locate and comprehend studies in the scientific literature.118 Even if the 
scientific studies are translated into language appropriate for a general audience, there 
must be caution about who is translating it. The ODS has a website that succinctly 
states what we understand about specific supplements, but it is limited to a small 
number of supplements.119 Claims by manufacturers, although required to be accurate, 
may put some marketing spin on the efficacy of their products. This finding places a 
lot of autonomy with the consumer, but there is currently no mechanism to help ensure 
that the autonomy is based on comprehension of available scientific data. 
Finding (12)(A), which addresses the U.S. economy, may be accurate.120 The 
dietary supplement industry is a more than thirty billion dollar per year endeavor.121 
Many members in Congress support the dietary supplement industry because it is a 
component of the local economies that they represent.122 It is unclear whether the 
economic benefit is a sufficient justification to maintain an industry, however. The 
cigarette industry likely has even larger sales than the dietary supplement industry, but 
the industry’s contribution to the U.S. economy is probably not a good justification for 
keeping cigarettes on the market, especially considering that health and productivity 
costs associated with cigarettes over a three-year period are in the hundreds of billions 
of dollars.123 
Finding (14), which addresses the safety of dietary supplements, is probably an 
inadequate statement given the growth and breadth of the industry.124 First, it is 
difficult to assess safety in the absence of scientific studies. Second, major adverse 
events related to supplement use have been reported, although they are likely 
underreported.125 Third, safety is not assessed prior to market entry. It is unclear on 
what basis Congress made this finding and, without additional scientific studies, its 
validity can and should be challenged. 
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The findings for the DSHEA are general statements that were made to support the 
legislative act. Twenty years later, we can reflect on whether the dietary supplement 
industry has proven the findings to be accurate, and whether some of the findings have 
become obsolete. At present, some scientific studies support the clinical use of dietary 
supplements to address some ailments,126 other studies warn of dangerous 
interactions,127 and even other studies demonstrate adverse health events associated 
with ingestion of dietary supplements.128 The dietary supplement industry may have 
grown into something that was unanticipated by Congress at the time it enacted the 
DSHEA. Regardless, whether the DSHEA properly governs this industry is certainly 
questionable. 
Moving beyond the findings, the DSHEA suffers from regulatory shortcomings. 
As mentioned throughout this article, the DSHEA places the burden on the FDA to 
demonstrate that a dietary supplement is unsafe.129 The DSHEA also provides that a 
new dietary ingredient can be included in a dietary supplement so long as the new 
ingredient has been present in the food supply in other ways or that it has been used in 
the way that the label suggests and the manufacturer can provide the FDA with safety 
information.130 These provisions provide only a small barrier to entry and little 
guidance as to applications. 
The ephedra alkaloid study described above is a good example of how challenging 
it can be to apply the DSHEA to various types of supplements, and how little 
regulation is imposed on the industry.131 As a result, the study found great variability 
in the forms of the stimulant ephedra, within lots and across products.132  
B. MAIN ISSUES 
Looking backwards on decades of problems associated with dietary supplements, 
the main concerns can be categorized as follows: (1) Formulation and Content; (2) 
Undisclosed Pharmaceuticals; (3) Classification, (4) Labeling; and (5) Scientific 
Studies. Some of these categories, by their nature, overlap. 
1. Formulation and Content 
Both the DSHEA and the FDA have rules regarding GMP.133 The DSHEA GMP 
rule includes requirements for process and quality control.134 This rule requires that 
manufacturers implement processes to ensure the quality of dietary supplements and 
use labels that accurately detail the components of the supplement.135 As part of this 
rule, the manufacturer is required to create a process to ensure the purity and 
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composition of any component of a dietary supplement.136 The DSHEA GMP rule 
places the burden on the manufacturer to ensure that their processes are accurate to 
meet the “established specifications,” including “identity, purity, strength, 
composition, and the limits on those types of contamination that may adulterate or that 
may lead to adulteration of the dietary supplement.”137 Manufacturers are required to 
maintain documentation regarding how they meet their specifications.138 This rule also 
addresses what to do when specifications are not met, requirements for adjustments, 
and what records to maintain.139 
The DSHEA GMP rule also addresses quality control, requiring quality control 
personnel to ensure that manufacturing and laboratory operations are designed to meet 
the manufacturers’ specifications.140 If a supplement is returned to the manufacturer, 
the rule provides the minimum requirements for quality control review and 
decisions.141 The rule also requires that manufacturers ensure uniformity in batch-to-
batch production and maintain records regarding the same.142 This section of the 
DSHEA GMP rule also addresses the procedures that must be followed when there is a 
product complaint: the manufacturer must determine the severity of the alleged 
problem and whether to investigate.143 
With respect to formulation and content, the DSHEA GMP rule requires a lot of 
record keeping and quality control, but provides no guidance about how these 
safeguards should be accomplished. Instead, this rule provides that the manufacturer 
must synthesize its own processes, procedures, and mechanisms for formulation and 
content of any particular dietary supplement.144 It is not clear how the manufacturer 
should even measure formulation and content—by biologic activity, absorption rate, or 
perhaps something else? In many ways, the FDA is limited in its ability to promulgate 
specific requirements because the FDA only has the authority to regulate supplements 
in the way that it regulates food, and the DSHEA provides that GMP cannot exceed 
what the FDA is allowed to require for non-supplement food. 
The DSHEA GMP rule does not specify how manufacturers are supposed to deal 
with isoforms or other molecular differences within a particular component. While this 
rule requires manufacturers to have processes in place to determine purity, it is unclear 
what level of purity this requires.145 In addition, as stated earlier, different isoforms of 
ephedra, for example, have different activity levels.146 Even if they all are pure 
ephedra, they can lead to different reactions and interactions.147 
The DSHEA GMP rule is  inadequate to address many of the actual problems with 
formulation and content of some dietary supplements. Plus, in accord with the 
DSHEA, the GMP rule can do very little to stop a supplement from getting to market; 
rather, the rule only allows for a review of the manufacturers’ processes once a 
problem has been discovered.148 
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2. Undisclosed Pharmaceuticals 
The incorporation of undisclosed pharmaceuticals into dietary supplements is a 
major problem. First, pharmaceuticals are considered drugs, not food—thus the FDA 
regulates them differently than food.149 Second, some pharmaceuticals are unsafe or 
ineffective and should not be in the chain of commerce, either as food or as drugs. 
In February of 2013, the FDA seized a number of dietary supplement products 
from the manufacturer Globe All Wellness.150 Globe All Wellness was accused of two 
serious violations. First, they marketed some of their products with claims that they 
could lower blood pressure and cholesterol; this is not permitted because supplements 
cannot claim to be intended for “diagnosis, cure, mitigation, treatment, or prevention 
of disease.”151 Second, some of the products contained sibutramine hydorcholoride, 
which had been an active ingredient in an obesity drug.152 The obesity drug was 
removed from the U.S. market after it was discovered that it led to serious health 
consequences, including heart attack and stroke.153 This active pharmaceutical was 
found in various products manufactured by Globe All Wellness.154 In addition, upon 
inspection, the FDA found that the manufacturer was not in compliance with the FDA 
GMP rule.155 
Similarly, the FDA issued a warning that some dietary supplements claiming to 
treat erectile dysfunction (ED) may contain undisclosed pharmaceuticals.156 Although 
these supplements state that they contain ‘natural’ cures for ED, it turns out that six of 
the seventeen products that the FDA analyzed contained sildenafil, which is the active 
ingredient in Viagra, or vardenafil, which is the active ingredient in Levitra.157 
Consumers who unknowingly ingest pharmaceuticals can experience serious side 
effects just by taking the drug alone, or by using them in combination with other 
prescription drugs.158 This same story can be told about other dietary supplements 
claiming to treat common illnesses, such as diabetes.159  
Sometimes the undisclosed pharmaceutical is an approved drug, sometimes it is a 
banned drug, and other times it is an adulterated form of a drug.160 The FDA 
acknowledged the problem that numerous dietary supplements contain undisclosed 
pharmaceuticals, banned pharmaceuticals, analogs, and new chemical ingredients.161 
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All of these violate the DSHEA and, of course, they are unapproved drugs, which 
violate the Food, Drug and Cosmetic Act.162 In addition, analogs and new chemical 
ingredients are of particular concern not only because of safety issues, but also because 
it is difficult to test for unknown chemical structures.163 
The FDA noted that the main types of dietary supplements that contain 
undisclosed pharmaceuticals are supplements that promote weight loss, sexual 
enhancement and bodybuilding.164 Consumers who choose to take supplements 
because they believe they are ingesting non-pharmaceutical agents are, in reality, not 
only consuming active pharmaceuticals, but may be at risk for experiencing serious 
side effects. Just because a label declares that the ingredients are ‘natural,’ that does 
not mean that the product is safe, effective, or even natural. 
3. Classification 
Dietary supplements are defined as: “(A) a vitamin; (B) a mineral; (C) an herb or 
other botanical; (D) an amino acid; (E) a dietary substance for use by man to 
supplement the diet by increasing the total dietary intake or (F) a concentrate, 
metabolite, constituent, extract, or combination of any ingredient described 
[above].”165 We know more about some dietary supplements on the market, such as 
Vitamin C, than we do about other supplements, such as weight loss supplements. 
Rather than lumping all dietary supplements together under one classification, simply 
as supplements and regulating all in the same way, it might make sense to create tiers 
or classifications.  
The classifications could be accomplished in a number of ways. One way could be 
to separate vitamins from botanicals, with vitamins requiring less regulatory control 
and botanicals requiring greater regulatory control. This distinction could help because 
botanicals is a large category with more unknown compounds and effects, so it might 
require greater pre-market controls, depending on the botanical.  
Another way to create categories is based on knowledge of safety. The ODS 
website synthesizes much of the information known about specific supplements.166 
Perhaps the more information that is known about a particular supplement, then 
satisfaction of fewer regulatory controls should be needed to enter the market. 
Conversely, the less that is known about structure, function, or interactions, then 
satisfaction of greater regulatory controls should be required prior to entry to market.  
The breadth and depth of the market for dietary supplements requires some 
reorganization for regulatory control. This suggested reorganization may incentivize 
manufacturers to get their supplements on the list of supplements for which more is 
known, thus lowering the barrier to entry to market. An opponent to this classification 
system might argue that the costs associated with conducting scientific studies to be on 
the “known” list will increase the cost of the supplement and this cost will be passed 
along to the consumers. In addition to increased costs, it may reduce consumer 
autonomy by delaying the availability of substances on the market. A response to this 
concern is that there are growing  safety concerns about supplements, the DSHEA 
findings may be inadequate, and thus a different regulatory tactic must be employed. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
162 Id. 
163 Cohen, supra note 28, at 1524. 
164 Letter from Hamburg, supra note 160. 
165 21 U.S.C § 321(ff) (2012). 
166 Supplement Fact Sheet, supra 87. 
AMERICAN JOURNAL OF LAW & MEDICINE 392 
4. Labeling 
Much effort and time is spent on ensuring that manufacturers label their 
supplements correctly in a number of ways, including identifying ingredients, not 
making false claims, and not claiming medical benefits. These requirements may not 
in reality be very valuable, as many consumers may not comprehend labels. Also, 
manufacturers may create labels that do not violate the language of labeling rules, yet 
still give the impression to consumers that the supplement alleviates medical 
conditions.  
Even with the caveat that labeling requirements may not actually inform the 
consumer, the labels are still lacking in a number of important ways. Labels do not, for 
example, state the isoforms of a particular ingredient. A dietary supplement may 
contain an ingredient that exists in multiple forms.167 The biochemical activity of the 
different forms may be very different.168 By way of example, different forms of 
ephedra alkaloids have different biochemical activity.169 If a label states that the 
dietary supplement contains ephedra, that information alone is not enough to 
understand the actual content of the supplement.  
In addition, the amount of ephedra, or any other ingredient, probably means very 
little to a consumer. Many consumers may not understand what the differences signify 
between twenty or fifty milligrams of any ingredient per tablet. A small difference in 
sodium content may have a negligible impact, but a small difference of a botanical 
ingredient in a supplement may have a huge impact. It depends on the biochemistry 
and absorption, and consumers may not be aware of this. Small variances in some 
types of ingredients have large impacts, while in other ingredients it does not make a 
practical difference. It is a great undertaking for a consumer to attempt to understand 
when content differences matter and when they do not. 
This raises the question of what information is actually helpful to the consumer. 
The labeling requirements should be structured to address this. Perhaps, manufacturers 
of dietary supplements who do not conduct any pre-market approval testing for safety 
or efficacy should have to place a large warning label informing the consumer: “This 
product has not be tested for safety or efficacy.” The manufacturer could then be 
exempt from this labeling requirement upon demonstrating that the product is safe and 
effective.  
5. Scientific Studies 
A main concern is that consumers believe that supplements do what they claim to 
do. Scientific studies can provide the basis for claims that dietary supplements actually 
supplement the diet in a beneficial way. Scientific studies do support the use of dietary 
supplements for specific reasons, such as using folic acid to support neural tube 
development.170 We also know that some dietary supplements that contain vitamins 
can be beneficial in individuals with a deficiency.171 We do not know whether  
supplemental vitamins have any benefit in individuals with healthy diets. We do know, 
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however, that too many supplemental vitamins and minerals cause harm in individuals; 
we know this can occur with Vitamin D, Vitamin E, and Iron.172  
Moving from vitamins to other types of supplements, we know very little about 
the ingredients in supplements that claim to assist, naturally, with weight loss or 
workouts. Putting aside the supplements that contain undisclosed or adulterated 
pharmaceuticals, we have a dearth of scientific studies supporting the manufacturers’ 
claims. We know that caffeine is one substance that assists with weight loss or 
workouts, but we only know that because we know a lot about caffeine from scientific 
studies.173  
It is unclear why some consumers trust untested supplements more than drugs, 
which are tested for safety and efficacy: perhaps it is because of ingenious marketing 
by the supplement industry; perhaps consumers do not trust pharmaceutical 
companies; perhaps consumers erroneously equate ‘natural’ with safe; perhaps it is 
simply the access to choice; or perhaps it is the difference in cost. None of these 
reasons, however, rely on scientific studies demonstrating safety or efficacy.  
It might even inure to a manufacturer’s benefit if it can claim that its supplement 
does what it says it does by citing to an objective scientific study. Of course, this 
requires time and money, which may not be in the immediate interest of the 
manufacturer. But, some supplements may be forced off the market due to violations 
of the DSHEA, while others, such as high quality folic acid, will remain. This is 
simply a business model choice, and studying their supplements may prove to greatly 
benefit companies. 
Another reason to promote scientific studies is to standardize procedures for 
formulation and content. Innovation in these areas can lead to consistency of content 
within and across batches. Content is a safety concern, with too little or too much of a 
particular ingredient leading to deleterious events.  
The findings of the DSHEA provide that “dietary supplements are safe within a 
broad range of intake, and safety problems with the supplements are relatively 
rare[.]”174 It is not clear that this finding can still be supported given the anecdotal and 
scientific evidence accumulated over the years. The FDA’s hands are tied by the 
DSHEA, which only allows it to remove a product from the market after it has been 
demonstrated to be harmful.175 Because we do not know that all dietary supplements 
are safe for consumption, it is not appropriate to continue to leave the DSHEA in 
place. After twenty years, it is time to re-evaluate the findings and the impact of the 
DSHEA. One way to re-evaluate is by conducting or requiring scientific studies prior 
to entry to market. 
Overall, the DSHEA has shortcomings in the five categories described above. A 
multi-tiered regulatory structure could be implemented to classify supplements into 
categories. Each category could contain appropriate requirements for regulation; 
scientific studies should be required to support each regulation or classification. 
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V. CONCLUSION 
The FSMA, passed in 2011, does very little to address the safety of dietary 
supplements. Through the lens of scientific studies, this article challenges the lack of 
regulatory authority given to the FDA to regulate the dietary supplement industry. 
Given the breadth and depth of the dietary supplement industry, a one-size-fits-all 
approach may not make sense. Thus, this article discusses a classification system—one 
that is based on safety and efficacy. Since the FSMA does little to address the dietary 
supplement industry, Congress should amend the FSMA to ensure that real, effective 
regulations govern the dietary supplement industry. 
